Related Experiment Videos
Bone marrow transplantation for Glanzmann's thrombasthenia
A Johnson1, A H Goodall, C J Downie
1Bone Marrow Transplant Unit, Westminster Children's Hospital, London, UK.
Bone Marrow Transplantation
|July 1, 1994
Summary
Allogeneic bone marrow transplantation (BMT) successfully treated a child with Glanzmann's thrombasthenia, a rare bleeding disorder. This therapy offers a potential long-term solution for patients with a matched donor.
Area of Science:
- Hematology
- Genetics
- Immunology
Background:
- Glanzmann's thrombasthenia is a rare inherited bleeding disorder.
- It results from a deficiency in the platelet glycoprotein IIb-IIIa complex.
- The condition often requires frequent hospitalizations due to bleeding complications.